ATE312350T1 - Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren - Google Patents

Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren

Info

Publication number
ATE312350T1
ATE312350T1 AT00969145T AT00969145T ATE312350T1 AT E312350 T1 ATE312350 T1 AT E312350T1 AT 00969145 T AT00969145 T AT 00969145T AT 00969145 T AT00969145 T AT 00969145T AT E312350 T1 ATE312350 T1 AT E312350T1
Authority
AT
Austria
Prior art keywords
neuronal activity
modulate neuronal
identifying connections
modulate
type
Prior art date
Application number
AT00969145T
Other languages
English (en)
Inventor
Terrance P Snutch
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE312350T1 publication Critical patent/ATE312350T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00969145T 1999-10-13 2000-10-13 Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren ATE312350T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15909599P 1999-10-13 1999-10-13
PCT/CA2000/001233 WO2001027630A2 (en) 1999-10-13 2000-10-13 Methods to identify compounds that modulate neuronal activity

Publications (1)

Publication Number Publication Date
ATE312350T1 true ATE312350T1 (de) 2005-12-15

Family

ID=22571069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969145T ATE312350T1 (de) 1999-10-13 2000-10-13 Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren

Country Status (9)

Country Link
US (1) US6531288B1 (de)
EP (1) EP1230551B1 (de)
JP (1) JP2003511087A (de)
AT (1) ATE312350T1 (de)
AU (1) AU7896700A (de)
CA (1) CA2385907A1 (de)
DE (1) DE60024664T2 (de)
ES (1) ES2253263T3 (de)
WO (1) WO2001027630A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296925A1 (en) * 2002-11-01 2004-06-07 Leucadia Technologies, Inc. Displacement sandwich immuno-pcr
US20050266524A1 (en) * 2003-12-03 2005-12-01 Bulla Lee A Beta integrin gene and protein
WO2006137933A2 (en) * 2004-11-03 2006-12-28 Leucadia Technologies, Inc. Microbubbles for affinity separation
ES2352041T5 (es) 2004-11-03 2014-12-22 Iris International, Inc. Detección homogénea de analitos
ES2433745T3 (es) * 2008-02-21 2013-12-12 Iris International, Inc. Procedimiento para la determinación temprana de recidivas tras la terapia para el cáncer de próstata

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US5623051A (en) 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers
JPH09299092A (ja) 1996-03-12 1997-11-25 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ

Also Published As

Publication number Publication date
DE60024664D1 (de) 2006-01-12
WO2001027630A3 (en) 2001-12-06
CA2385907A1 (en) 2001-04-19
AU7896700A (en) 2001-04-23
JP2003511087A (ja) 2003-03-25
US6531288B1 (en) 2003-03-11
ES2253263T3 (es) 2006-06-01
EP1230551B1 (de) 2005-12-07
WO2001027630A2 (en) 2001-04-19
DE60024664T2 (de) 2006-07-06
EP1230551A2 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
WO2003104418A3 (en) Reconstituted polypeptides
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
IL130036A0 (en) Survivin a protein that inhibits cellular apoptosis and its modulation
AU735355C (en) Novel protein and method for producing the protein
ATE445642T1 (de) Trennung von polypeptiden mit einer racemisierten aminosäure
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE50012831D1 (de) Verfahren zur verbindung von molekularen substanzen
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
DE69618614D1 (de) NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
ATE403864T1 (de) Verfahren zur identifizierung von substanzen, die die aktivität von hyperpolarisations-aktivierten kationen-kanälen modulieren
ATE312350T1 (de) Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren
DE69927691D1 (de) Verfahren zur eiweissanalyse
WO2003106650A3 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AUPP627498A0 (en) Novel peptides - i
DE69927400D1 (de) Pge synthase und verfahren und mitteln zur modulation deren aktivität
AU6318301A (en) Cng3b: a novel cyclic nucleotide-gated cation channel
AU8488401A (en) Cng2b: a novel human cyclic nucleotide-gated ion channel
DE69806107D1 (de) Methoden und reagenzien zur regulierung von apoptosis
ATE336508T1 (de) Kaliumkanalprotein kcnq5, ein ziel für erkrankungen des zentralen nervensystems und herz-gefäss-systems
WO2004047758A3 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
WO2003006673A3 (en) A nucleic acid encoding a human junctional adhesion protein (jam3)
WO2004044162A3 (en) HUMAN ACID-SENSING ION CHANNEL 2b (hASIC2b)
EP1329503A4 (de) Sphingolipid-ceramiddeacylase-gen
EP0716146A3 (de) Markerprotein für Stammzelle, dagegen gerichtete Antikörper, diese enthaltende Zusammensetzungen sowie für diesem Protein kodierende Nukleotidsequenzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties